Cargando…

SARS-CoV-2 infection serology: a useful tool to overcome lockdown?

The outbreak of 2019 novel coronavirus disease (Covid-19) caused by SARS-CoV-2 has spread rapidly, inducing a progressive growth in infected patients number. Social isolation (lockdown) has been assessed to prevent and control virus diffusion, leading to a worldwide financial and political crisis. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuccetelli, Marzia, Pieri, Massimo, Grelli, Sandro, Ciotti, Marco, Miano, Roberto, Andreoni, Massimo, Bernardini, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249039/
https://www.ncbi.nlm.nih.gov/pubmed/32501411
http://dx.doi.org/10.1038/s41420-020-0275-2
_version_ 1783538511113093120
author Nuccetelli, Marzia
Pieri, Massimo
Grelli, Sandro
Ciotti, Marco
Miano, Roberto
Andreoni, Massimo
Bernardini, Sergio
author_facet Nuccetelli, Marzia
Pieri, Massimo
Grelli, Sandro
Ciotti, Marco
Miano, Roberto
Andreoni, Massimo
Bernardini, Sergio
author_sort Nuccetelli, Marzia
collection PubMed
description The outbreak of 2019 novel coronavirus disease (Covid-19) caused by SARS-CoV-2 has spread rapidly, inducing a progressive growth in infected patients number. Social isolation (lockdown) has been assessed to prevent and control virus diffusion, leading to a worldwide financial and political crisis. Currently, SARS-CoV-2 RNA detection in nasopharyngeal swab takes place by real-time PCR (RT-qPCR). However, molecular tests can give some false-negative results. In this context, serological assays can be useful to detect IgG/IgM antibodies, to assess the degree of immunization, to trace the contacts, and to support the decision to re-admit people at work. A lot of serological diagnostic kits have been proposed on the market but validation studies have not been published for many of them. The aim of our work was to compare and to evaluate different assays analytical performances (two different immunochromatographic cards, an immunofluorescence chromatographic card, and a chemiluminescence-automated immunoassay) on 43 positive samples with RT-qPCR-confirmed SARS-CoV-2 infection and 40 negative control subjects. Our data display excellent IgG/IgM specificities for all the immunocromatographic card tests (100% IgG and 100% IgM) and for the chemiluminescence-automated assay (100% IgG and 94% IgM); IgG/IgM sensitivities are moderately lower for all methods, probably due to the assay viral antigen’s nature and/or to the detection time of nasopharyngeal swab RT-qPCR, with respect to symptoms onset. Given that sensitivities (around 94% and 84% for IgG and IgM, respectively) implicate false-negative cases and given the lack of effective vaccines or treatments, the only currently available procedure to reduce SARS-CoV-2 transmission is to identify and isolate persons who are contagious. For this reason, we would like to submit a flowchart in which serological tests, integrated with nasopharyngeal swab RT-qPCR, are included to help social and work activities implementation after the pandemic acute phase and to overcome lockdown.
format Online
Article
Text
id pubmed-7249039
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72490392020-05-26 SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Nuccetelli, Marzia Pieri, Massimo Grelli, Sandro Ciotti, Marco Miano, Roberto Andreoni, Massimo Bernardini, Sergio Cell Death Discov Article The outbreak of 2019 novel coronavirus disease (Covid-19) caused by SARS-CoV-2 has spread rapidly, inducing a progressive growth in infected patients number. Social isolation (lockdown) has been assessed to prevent and control virus diffusion, leading to a worldwide financial and political crisis. Currently, SARS-CoV-2 RNA detection in nasopharyngeal swab takes place by real-time PCR (RT-qPCR). However, molecular tests can give some false-negative results. In this context, serological assays can be useful to detect IgG/IgM antibodies, to assess the degree of immunization, to trace the contacts, and to support the decision to re-admit people at work. A lot of serological diagnostic kits have been proposed on the market but validation studies have not been published for many of them. The aim of our work was to compare and to evaluate different assays analytical performances (two different immunochromatographic cards, an immunofluorescence chromatographic card, and a chemiluminescence-automated immunoassay) on 43 positive samples with RT-qPCR-confirmed SARS-CoV-2 infection and 40 negative control subjects. Our data display excellent IgG/IgM specificities for all the immunocromatographic card tests (100% IgG and 100% IgM) and for the chemiluminescence-automated assay (100% IgG and 94% IgM); IgG/IgM sensitivities are moderately lower for all methods, probably due to the assay viral antigen’s nature and/or to the detection time of nasopharyngeal swab RT-qPCR, with respect to symptoms onset. Given that sensitivities (around 94% and 84% for IgG and IgM, respectively) implicate false-negative cases and given the lack of effective vaccines or treatments, the only currently available procedure to reduce SARS-CoV-2 transmission is to identify and isolate persons who are contagious. For this reason, we would like to submit a flowchart in which serological tests, integrated with nasopharyngeal swab RT-qPCR, are included to help social and work activities implementation after the pandemic acute phase and to overcome lockdown. Nature Publishing Group UK 2020-05-26 /pmc/articles/PMC7249039/ /pubmed/32501411 http://dx.doi.org/10.1038/s41420-020-0275-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Nuccetelli, Marzia
Pieri, Massimo
Grelli, Sandro
Ciotti, Marco
Miano, Roberto
Andreoni, Massimo
Bernardini, Sergio
SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
title SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
title_full SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
title_fullStr SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
title_full_unstemmed SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
title_short SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
title_sort sars-cov-2 infection serology: a useful tool to overcome lockdown?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249039/
https://www.ncbi.nlm.nih.gov/pubmed/32501411
http://dx.doi.org/10.1038/s41420-020-0275-2
work_keys_str_mv AT nuccetellimarzia sarscov2infectionserologyausefultooltoovercomelockdown
AT pierimassimo sarscov2infectionserologyausefultooltoovercomelockdown
AT grellisandro sarscov2infectionserologyausefultooltoovercomelockdown
AT ciottimarco sarscov2infectionserologyausefultooltoovercomelockdown
AT mianoroberto sarscov2infectionserologyausefultooltoovercomelockdown
AT andreonimassimo sarscov2infectionserologyausefultooltoovercomelockdown
AT bernardinisergio sarscov2infectionserologyausefultooltoovercomelockdown